公司资料
IO Biotech 股价、新闻与催化剂
- 股票代码:
- IOBT
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- Denmark
股价为何变动
Current closing-price context is not available for IOBT.
公司概览
业务概览
IO Biotech is an immuno-oncology company focused on cancer vaccines and immune-modulating therapies. Its platform aims to create differentiated immunotherapy in solid tumors.
所在地与行业分类
Headquartered in Denmark and listed on NASDAQ as an ADR, IO Biotech has a global oncology-biotech profile.
商业模式特征
The company depends on clinical data, immune-response validation, and the ability to create a durable cancer-vaccine platform.
生物医药行业定位
IO Biotech is a catalyst-driven oncology name whose valuation depends on early clinical outcomes.
未来催化剂
- IO Biotech’s catalysts are Cylembio and the cancer-vaccine program, especially any update that keeps the immuno-oncology platform moving. The company needs human data to support the thesis.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。